Farmak JSC added Nalbuk, a drug for treatment of pain syndrome, to its product portfolio. The new drug is manufactured in the form of solution for injection in 1 or 2 ml ampoule No. 5 or 1 ml syringe No. 5.
Nalbuk is developed on the basis of the active substance nalbuphine. The product is used for treatment of moderate to severe pain. In addition, Nalbuk is recommended for use as a supplementary analgesic drug, to relieve pain during pre- and postoperative period, and for childbirth anesthesia.
Vlast Deneg [The Power of Money] magazine has published the rating of TOP 25 successful marketing campaigns held in the Ukrainian market in 2020 – the first half of 2021. The rating includes marketing projects implemented by both domestic companies and Ukrainian representative offices of foreign companies. The leaders include: Farmak, Carlsberg Ukraine, Avon...
Each city or town has its own traditions. We follow the old and develop the new ones ourselves. It has become a good tradition for Farmak to congratulate Shostka on its Town Day in a sporty way. The anniversary race “Farmak: Run for Your Health” has been held by the Company for the fifth time. […]
The 5th anniversary race organized by Farmak on the occasion of Shostka Town Day will be held with the support of the local authorities in an offline format under the motto “Run a race and take care of your health!” The race will take place on September 3 in Shostka as part of the celebration of […]